Health

Fewer Australians are dying from hepatitis C, but thousands are still missing out on treatment – Health

Fewer Australians are dying from hepatitis C, but thousands are still missing out on treatment – Health

The number of Australians dying from liver failure and liver cancer related to hepatitis C has dropped by 20 per cent in just two years, according to preliminary data released today by The Kirby Institute.

It follows the introduction of highly effective, low-cost curative drugs to the Pharmaceutical Benefits Scheme (PBS) in 2016.

“This decline reflects the high uptake of direct-acting antiviral therapies among people with hepatitis C, particularly those with more advanced liver disease,” said Greg Dore from the Kirby Institute.

“Since 2016, around 60,000 Australians have been treated with the highly curative therapies, and now for the first time, we are seeing fewer people dying of hepatitis C-related causes.”